Results 41 to 50 of about 493,126 (165)

Capacity and cost benefits of subcutaneous versus intravenous pertuzumab/trastuzumab: The EASE-SC study

Breast
Objectives: Subcutaneous administration of pertuzumab and trastuzumab offers a faster alternative to intravenous infusion for patients with HER2-positive breast cancer.
Michiel Zietse, Jacky Hu, Esther R. van Staveren, Leontine E.A.M.M. Spierings, Agnes Jager, Birgit C.P. Koch, Ron H.J. Mathijssen, Roelof W.F. van Leeuwen, Frederick W. Thielen   +8 more
doaj   +1 more source

Frontline nursing staff’s perceptions of intravenous medication administration: the first step toward safer infusion processes—a qualitative study

BMJ Open Quality
Objectives Intravenous medication errors continue to significantly impact patient safety and outcomes. This study sought to clarify the complexity and risks of the intravenous administration process.Design A qualitative focus group interview study ...
paul Barach, Yoshikazu Fujisawa, Masashi Uramatsu, Takako Kojima, Naoko Kimura, Tomoko Oto   +5 more
doaj   +1 more source

Evaluating the safety, pharmacokinetics and efficacy of phage therapy in treating fracture-related infections with multidrug-resistant Staphylococcus aureus: intravenous versus local application in sheep

Frontiers in Cellular and Infection Microbiology
BackgroundFracture-related infections (FRI), particularly those caused by antibiotic resistant Staphylococcus aureus, present significant clinical challenges due to the formation of biofilm on the implanted device, and reduced options for conventional ...
Christian Peez, Christian Peez, Baixing Chen, Baixing Chen, Baixing Chen, Leopold Henssler, Leopold Henssler, Marco Chittò, Jolien Onsea, Jolien Onsea, Michael H. J. Verhofstad, Daniel Arens, Caroline Constant, Stephan Zeiter, William Obremskey, Andrej Trampuz, Michael J. Raschke, Charalampos Zalavras, Willem-Jan Metsemakers, Willem-Jan Metsemakers, T. Fintan Moriarty   +20 more
doaj   +1 more source

The burden of systemic therapy administration route in treating HER2-positive breast cancer (for patients, healthcare professionals, and healthcare system): a systematic literature review

Frontiers in Pharmacology
IntroductionBreast cancer (BC) is one of the leading causes of cancer and is the first cause of death from malignant tumors among women worldwide. New cancer therapies receive regulatory approval yearly and to avoid health disparities in society, the ...
Luciana Castro Garcia Landeiro, Tamie de Camargo Martins, Ruth Bartelli Grigolon, Isabel Monteiro, Joana Bisol Balardin, Eduardo Padilha, Gilberto Amorim, Stephen Stefani   +7 more
doaj   +1 more source

Preincisional administration of intravenous or subcutaneous infiltration of low-dose ketamine suppresses postoperative pain after appendectomy

Journal of Pain Research, 2011
Azim Honarmand, Mohammadreza Safavi, Hasan KarakyAnesthesiology and Critical Care Research Center, Isfahan University of Medical Sciences, Isfahan, IranBackground: Ketamine, an N-methyl-D-aspartate receptor antagonist, can suppress hyperalgesia and ...
Honarm, A, Safavi M, Karaky H
doaj  

Intravenous administration of colchicine [PDF]

Arthritis & Rheumatism, 1981
openaire   +2 more sources

Clinical Effectiveness of Intravenous Peramivir versus Oseltamivir for the Treatment of Influenza in Hospitalized Patients

Infection and Drug Resistance, 2020
Jin Seo Lee,1 Mi Suk Lee,2 Yoonseon Park,3 Jacob Lee,4 Eun-Jeong Joo,5 Joong Sik Eom6 1Division of Infectious Disease, Department of Medicine, Hallym University Kangdong Sacred Heart Hospital, Seoul, Republic of Korea; 2Division of Infectious Diseases ...
Lee JS, Lee MS, Park Y, Lee J, Joo EJ, Eom JS   +5 more
doaj  

Rate of administration of intravenous ondansetron

Indian Journal of Anaesthesia, 2011
Smita Prakash, Meenu Aggarwal
doaj   +1 more source

Comparison of ketorolac intravenous versus acetaminophen intravenous in treating headache following head trauma: a semi-experimental study

Chinese Neurosurgical Journal
Background Post-traumatic headache is a disabling secondary headache disorder often attributed to traumatic brain injury and affects millions of individuals worldwide.
Behzad Zohrevandi, Marjan Hosseinnia, Niloufar Balikshahi, Masoud Jobaneh, Ehsan Kazemnezhad Leili, Naema Khodadadi-Hassankiadeh   +5 more
doaj   +1 more source

First-in-human clinical outcomes with NG-350A, an anti-CD40 expressing tumor-selective vector designed to remodel immunosuppressive tumor microenvironments

Journal for ImmunoTherapy of Cancer
Background Tumor-selective oncolytic viral vectors are promising anticancer therapeutics; however, challenges with dosing and potency in advanced/metastatic cancers have limited efficacy and usage.
Aung Naing, Danny Khalil, Matthew Thomas, Tom Lillie, Oliver Rosen, Lee Rosen, D Ross Camidge, Rui-Ru Ji, Andrea Stacey   +8 more
doaj   +1 more source